Emergent BioSolutions Inc. — Director's Dealing 2020

Aug 11, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-08-07

Reporting Person: Richard Ronald (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-07	Common Stock	S	6297	$131	Disposed	8276	Direct

Footnotes

F1: Consists of restricted stock units granted under the Company's Stock Incentive Plan, as amended and restated.

F2: Due to a computational error in the Form 4 filed on February 25, 2020, Mr. Richard's subsequently filed From 4s showed the incorrect amount of securities beneficially owned. The amount of securities beneficially owned has been corrected herein.